Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.240
+0.040 (3.33%)
Jan 2, 2025, 4:00 PM EST - Market closed
Barinthus Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 2, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 50 | 142 | 88 | 388 | - | - |
| Market Cap Growth | -60.62% | 62.36% | -77.38% | - | - | - |
| Enterprise Value | -44 | -5 | -104 | 162 | - | - |
| Last Close Price | 1.24 | 3.69 | 2.35 | 11.11 | - | - |
| PE Ratio | - | - | 16.41 | - | - | - |
| PS Ratio | 3.23 | 177.44 | 1.96 | 1445.93 | - | - |
| PB Ratio | 0.31 | 0.76 | 0.36 | 1.53 | - | - |
| P/TBV Ratio | 0.38 | 0.95 | 0.43 | 1.86 | - | - |
| EV/Sales Ratio | - | - | - | 605.57 | - | - |
| Debt / Equity Ratio | 0.08 | 0.07 | 0.04 | 0.03 | -14.73 | 0.15 |
| Asset Turnover | 0.07 | 0.00 | 0.16 | 0.00 | 0.14 | - |
| Quick Ratio | 8.43 | 11.91 | 16.87 | 19.81 | 6.12 | 2.67 |
| Current Ratio | 8.93 | 12.45 | 17.40 | 20.32 | 6.27 | 2.83 |
| Return on Equity (ROE) | -32.60% | -34.15% | 2.15% | -40.99% | -420.05% | - |
| Return on Assets (ROA) | -18.65% | -20.73% | -0.65% | -15.55% | -30.07% | - |
| Return on Capital (ROIC) | -20.52% | -22.24% | -0.70% | -17.00% | -36.98% | - |
| Earnings Yield | -115.92% | -51.54% | 6.09% | -13.13% | - | - |
| FCF Yield | -124.47% | -39.59% | -23.47% | -8.70% | - | - |
| Buyback Yield / Dilution | -2.31% | -0.57% | -47.40% | -227.59% | -33580.72% | - |
| Total Shareholder Return | -2.31% | -0.57% | -47.40% | -227.59% | -33580.72% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.